β-Endorphin Immunoreactive Material and Authentic β-Endorphin in the Plasma of Males Undergoing Anaerobic Exercise on a Rowing Ergometer

Adrenocorticotropic hormone (ACTH), β-endorphin immunoreactive material (β-endorphin IRM), and authentic β-endorphin (1 - 31) have been determined in the plasma of 23 volunteers undergoing anaerobic exercise on a rowing ergometer. The volunteers had different histories of training from occasional physical activities up to intensive preparation for international rowing competitions. ACTH and β-endorphin-IRM were determined using commercially available immunometric assays; for determination of β-endorphin (1 - 31) a highly specific two-site fluid phase immunoprecipitation radioimmunoassay was developed, which did not cross-react with any β-endorphin derivative or any other opioid peptide tested. In agreement with reports from the literature ACTH and β-endorphin-IRM concentrations in the plasma rose upon anaerobic exercise in all 23 subjects; this increase in the ACTH and β-endorphin IRM levels was significantly correlated with the increase of lactate levels observed upon anaerobic exercise. Authentic β-endorphin (1 - 31) was only found in two plasma samples containing minor concentrations of the peptide. We conclude that the β-endorphin immunoreactive material released into blood under anaerobic exercise is identical with authentic β-endorphin (1 - 31) only to a minor extent and thus should not be called “β-endorphin”. The major part of the material in fact released into the blood upon anaerobic exercise is probably identical with β-lipotropin and further components so far unknown.

Physical stress, opioid peptides, ACTH, lactate, fluid phase immunoprecipitation two-site radioimmunoassay.

References

• 01 Carr D JJ. The role of endogenous opioids and their receptors in the immune system.  Proc Soc Exp Biol Med. 1991;  198 710-720
• 02 Chan E C, Smith R. Beta-endorphin immunoreactivity during human pregnancy.  J Clin Endocrinol Metab. 1992;  75 1453-1458
• 03 Cumming D C, Wheeler G D. Opioids in exercise physiology.  Seminars in Reproductive Endocrinology. 1987;  5 171-179
• 04 Elias A N, Fairshter R, Pandian M R, Domurat E, Kayaleh R. β-Endorphin/β-lipotropin release and gonadotropin secretion after acute exercise in physically conditioned males.  Eur J Appl Physiol. 1989;  58 522-527
• 05 Engfred K, Kjaer M, Secher N H, Friedman D B, Hanel B, Nielsen O J, Bach F W, Galbo H, Levine B D. Hypoxia and training-induced adaptation of hormonal responses to exercise in humans.  Eur J Appl Physiol. 1994;  68 303-309
• 06 Farrell P A, Kjaer M, Bach F W, Galbo H. Beta-endorphin and adrenocorticotropin response to supramaximal treadmill exercise in trained and untrained males.  Acta Physiol Scand. 1987;  130 619-625
• 07 Gramsch C, Meo T, Riethmüller G, Herz A. Binding characteristics of a monoclonal β-endorphin antibody recognizing the N-terminus of opioid peptides.  J Neurochem. 1983;  40 1220-1226
• 08 Heitkamp H-C, Schmid K, Scheib K. β-Endorphin and adrenocorticotropic hormone production during marathon and incremental exercise.  Eur J Appl Physiol. 1993;  66 269-274
• 09 Hildebrand A, Preissner K T, Müller-Berghaus G, Teschemacher H. A novel β-endorphin binding protein. Complement S protein (= vitronectin) exhibits specific non-opioid binding sites for β-endorphin upon interaction with heparin or surfaces.  J Biol Chem. 1989;  264 15 429-15 434
• 10 Hollmann W, Rost R, De Meirleir K, Liesen H, Heck H, Mader A. Cardiovascular effects of extreme physical training.  Acta Med Scand (Suppl). 1986;  711 193-203
• 11 Höllt V. Opioid peptide processing and receptor selectivity.  Ann Rev Pharmacol Toxicol. 1986;  26 59-77
• 12 Knudtzon J. Effects of pro-opiomelanocortin-derived peptides on plasma levels of glucagon, insulin and glucose.  Horm Metabol Res. 1986;  18 579-583
• 13 Kraemer W J, Hamilton A J, Gordon S E, Trad L A, Reeves J T, Zahn D W, Cymerman A. Plasma changes in beta-endorphin to acute hypobaric hypoxia and high intensity exercise.  Aviat Space Environ Med. 1991;  62 754-758
• 14 Kraemer W J, Dziados J E, Marchitelli L J, Gordon S E, Harman E A, Mello R, Fleck S J, Frykman P N, Triplett N T. Effects of different heavy-resistance exercise protocols on plasma β-endorphin concentrations.  J Appl Physiol. 1993;  74 450-459
• 15 McLoughlin L, Evans S F, Watson J D, Hinds C J, Rees L H. Characterization of circulating pro-opiomelanocortin-related peptides in human septic shock.  J Endocrinol. 1988;  119 159-165
• 16 McLoughlin L, Medbak S, Grossman A B. Circulating opioids in man. In: Herz A, Akil H, Simon EJ, (eds) Handbook of Experimental Pharmacology 104/II (Opioids II). Berlin; Springer 1993: 673-696
• 17 Oleshansky M A, Zoltick J M, Herman R H, Mougey E H, Meyerhoff J L. The influence of fitness on neuroendocrine responses to exhaustive treadmill exercise.  Eur J Appl Physiol. 1990;  59 405-410
• 18 Owens P C, Smith R. Opioid peptides in blood and cerebrospinal fluid during acute stress.  Baillière's Clin Endocrinol Metab. 1987;  1 415-437
• 19 Petraglia F, Barletta C, Facchinetti F, Spinazzola F, Monzani A, Scavo D, Genazzani A R. Response of circulating adrenocorticotropin, beta-endorphin, beta-lipotropin and cortisol to athletic competition.  Acta Endocrinol (Copenh.). 1988;  118 332-336
• 20 Pierce E F, Eastman N W, Tripathi H T, Olson K G, Dewey W L. Plasma β-endorphin immunoreactivity: Response to resistance exercise.  J Sports Sci. 1993;  11 499-502
• 21 Pierce E F, Eastman N W, McGowan R W, Tripathi H, Dewey W L, Olson K G. Resistance exercise decreases β-endorphin immunoreactivity.  Br J Sports Med. 1994;  28 164-166
• 22 Prasad R, Bhargava H N. Detection of β-endorphin in human blood.  Arch Pathol Lab Med. 1992;  116 827-830
• 23 Raff H, Shaker J L, Nelson D K, Findling J W. Rapid measurement of corticotropin (ACTH) with a modified immunochemiluminescent assay.  Clin Chem. 1994;  40 1344
• 24 Rahkila P, Hakala E, Alén M, Salminen K, Laatikainen T. β-endorphin and corticotropin release is dependent on a threshold intensity of running exercise in male endurance athletes.  Life Sci. 1988;  43 551-558
• 25 Schwarz L, Kindermann W. β-Endorphin, adrenocorticotropic hormone, cortisol and catecholamines during aerobic and anaerobic exercise.  Eur J Appl Physiol. 1990;  59 165-171
• 26 Schwarz L, Kindermann W. Changes in β-endorphin levels in response to aerobic and anaerobic exercise.  Sports Med. 1992;  13 25-36
• 27 Schweigerer L, Schmidt W, Teschemacher H, Gramsch C. β-Endorphin: Surface binding and internalization in thymoma cells.  Proc Natl Acad Sci USA. 1985;  82 5751-5755
• 28 Steinberg H, Sykes E A. Introduction to symposium on endorphins and behavioural processes; Review of literature on endorphins and exercise.  Pharmacol Biochem Behav. 1985;  23 857-862
• 29 Taylor D V, Boyajian J G, James N, Woods D, Chicz-Demet A, Wilson A F, Sandman C A. Acidosis stimulates β-endorphin release during exercise.  J Appl Physiol. 1994;  77 1913-1918
• 30 Teschemacher H, Koch G, Kramer D, Wiedemann K. β-Endorphin immunoreactive material in the plasma: What does it mean?. In: Distler W, Beck L, (eds) Endorphins in reproduction and stress. Springer; Berlin 1990: 93-98
• 31 Teschemacher H, Koch G, Scheffler H, Hildebrand A, Brantl V. Opioid Peptides. Immunological significance?.  Ann New York Acad Sci. 1990;  594 66-77
• 32 Viru A, Tendzegolskis Z. Plasma endorphin species during dynamic exercise in humans.  Clin Physiol. 1995;  15 73-79
• 33 Wanke T, Auinger M, Formanek D, Merkle M, Lahrmann H, Ogris E, Zwick H, Irsigler K. Defective endogenous opioid response to exercise in type I diabetic patients.  Metabolism. 1996;  45 137-142
• 34 Wiedemann K, Teschemacher H. β-Endorphin immunoreactive materials in human plasma determined by a multiple radioimmunoassay system.  Life Sci (Suppl. I). 1983;  33 89-92
• 35 Wiedemann K, Teschemacher H. Determination of β-endorphin and fragments thereof in human plasma using high-performance liquid chromatography and a multiple radioimmunoassay system.  Pharmaceut Res. 1986;  3 142-149
• 36 Wortsman J, Frank S, Wehrenberg W B, Petra P H, Murphy J E. Gamma 3-Melanocyte-stimulating hormone immunoreactivity is a component of the neuroendocrine response to maximal stress (cardiac arrest).  J Clin Endocrinol Metab. 1985;  61 355-360
• 37 Young E, Bronstein D, Akil H. Proopiomelanocortin biosynthesis, processing, and secretion: Functional implications. In: Herz A, Akil H, Simon EJ, (eds) Handbook of Experimental Pharmacology 104/I (Opioids I). Berlin; Springer 1993: 393-421